Pediatrix Medical Q3 Earnings Beat Estimates on Declining Expenses

Key Takeaways Pediatrix Medical's Q3 EPS rose 52.3% year over year, beating consensus by 45.7%.Same-unit revenues climbed 8% on stronger reimbursement factors and patient acuity.Operating expenses fell 11%, helping EBITDA jump 45% and net income reach $71.7 million.Pediatrix Medical Group, Inc. (MD) reported third-quarter 2025 adjusted earnings per share (EPS) of 67 cents, which surpassed the Zacks Consensus Estimate by 45.7%. The bottom line surged 52.3% year over year.Net revenues tumbled 3.6% year over y ...